Abbott India Ltd. Technical Momentum Shifts to Bearish Amid Market Volatility

Technical Trend Overview and Price Movement

As of 5 Oct 2026, Abbott India’s stock closed at ₹26,832.10, down 1.17% from the previous close of ₹27,149.40. The intraday range saw a high of ₹27,335.00 and a low of ₹26,435.30, indicating increased volatility. The stock remains comfortably above its 52-week low of ₹25,140.50 but is still some distance from its 52-week high of ₹30,598.00, signalling a period of consolidation and pressure on upward momentum.

The technical trend has shifted from mildly bullish to bearish, a significant change that warrants close attention from investors. This shift is corroborated by multiple technical indicators across different time frames, suggesting a weakening of the stock’s upward momentum and potential for further downside in the near term.

MACD and RSI Signal Deterioration

The Moving Average Convergence Divergence (MACD) indicator, a key momentum oscillator, is bearish on both weekly and monthly charts. This dual timeframe bearishness indicates sustained selling pressure and a lack of bullish crossover signals that typically precede upward price moves. The weekly MACD’s bearish stance suggests short-term momentum is weakening, while the monthly MACD confirms a longer-term downtrend.

Similarly, the Relative Strength Index (RSI) on the weekly chart has turned bearish, reflecting increased selling pressure and a potential move towards oversold territory. However, the monthly RSI currently shows no clear signal, indicating that while short-term momentum is faltering, the longer-term momentum remains neutral. This divergence between weekly and monthly RSI readings suggests that the stock may be undergoing a corrective phase rather than a full reversal of its long-term trend.

Moving Averages and Bollinger Bands Indicate Bearish Bias

Abbott India’s daily moving averages have turned bearish, with the stock price trading below key averages such as the 50-day and 200-day moving averages. This technical configuration often signals a downtrend and can act as resistance levels, limiting near-term upside potential.

Bollinger Bands on the weekly chart are currently moving sideways, indicating a period of consolidation with no clear directional bias. However, the monthly Bollinger Bands have turned bearish, suggesting that volatility is increasing on a longer-term basis with a downward price bias. This combination points to a cautious outlook where short-term price fluctuations may be range-bound, but the broader trend favours downside risk.

Additional Technical Indicators: KST, Dow Theory, and OBV

The Know Sure Thing (KST) indicator, which aggregates multiple rate-of-change measures, is mildly bearish on the weekly chart and bearish on the monthly chart. This reinforces the view that momentum is weakening across both short and longer-term horizons.

Interestingly, Dow Theory readings present a mixed picture. The weekly Dow Theory remains mildly bullish, suggesting some underlying strength or accumulation in the short term. However, the monthly Dow Theory shows no clear trend, indicating uncertainty in the broader market context for Abbott India.

On the volume front, the On-Balance Volume (OBV) indicator is mildly bullish on the weekly timeframe, signalling that volume trends may still be supporting price stability or accumulation despite the bearish momentum indicators. The monthly OBV, however, shows no discernible trend, aligning with the neutral monthly RSI and Dow Theory signals.

Comparative Performance Against Sensex

From a returns perspective, Abbott India has outperformed the Sensex over several key periods despite recent technical weakness. The stock delivered a 1-month return of +2.66% compared to the Sensex’s -6.54%, and a year-to-date return of -7.70% versus the Sensex’s -15.62%. Over three years, Abbott India’s return stands at +15.86%, outperforming the Sensex’s +9.24%. Even over a decade, the stock has delivered a remarkable 468.10% return, significantly ahead of the Sensex’s 158.06%.

However, the recent downgrade in the Mojo Grade from Hold to Sell on 28 Sep 2026, with a current Mojo Score of 48.0, reflects the technical deterioration and growing caution among analysts. This downgrade aligns with the bearish technical signals and suggests investors should exercise prudence in the near term.

Implications for Investors and Outlook

The convergence of bearish signals across MACD, RSI, moving averages, and KST indicates that Abbott India is currently facing downward momentum pressures. While volume-based indicators and some short-term Dow Theory signals hint at pockets of support, the overall technical landscape suggests a cautious stance is warranted.

Investors should monitor key support levels near the 52-week low of ₹25,140.50 and watch for any reversal signals in monthly indicators before considering fresh positions. The stock’s strong long-term fundamentals and historical outperformance relative to the Sensex provide a buffer, but the current technical environment advises a defensive approach.

Conclusion

Abbott India Ltd. is currently navigating a challenging technical environment marked by a shift to bearish momentum across multiple indicators. While the stock’s long-term performance remains impressive, the recent downgrade to a Sell rating and the prevailing technical signals suggest investors should adopt a cautious stance. Close monitoring of key support levels and technical indicators will be essential to gauge any potential recovery or further downside risk.

Given the mixed signals from volume and Dow Theory indicators, the stock may experience short-term consolidation before a clearer directional trend emerges. For investors seeking exposure to the Pharmaceuticals & Biotechnology sector, it may be prudent to consider alternative opportunities or await confirmation of a technical turnaround in Abbott India’s price action.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today